CCN2 and diabetic kidney disease: They examined the effect of CTGF on the progression of renal scarring in long-term STZ-induced diabetic nephropathy, in the advanced stage of obstructive nephropathy following UUO and in aristolochic acid (AA)-induced tubulotoxic nephritis by using heterozygous CTGF knockout mice.